Jeonjinbio Co., Ltd. (KOSDAQ:110020)

Jeonjinbio Statistics

Total Valuation

Jeonjinbio has a market cap or net worth of KRW 20.47 billion. The enterprise value is 14.06 billion.

Market Cap	20.47B
Enterprise Value	14.06B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

Jeonjinbio has 9.06 million shares outstanding. The number of shares has increased by 3.42% in one year.

Current Share Class	9.06M
Shares Outstanding	9.06M
Shares Change (YoY)	+3.42%
Shares Change (QoQ)	-6.98%
Owned by Insiders (%)	6.84%
Owned by Institutions (%)	n/a
Float	7.94M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.49
PB Ratio	1.18
P/TBV Ratio	1.18
P/FCF Ratio	n/a
P/OCF Ratio	42.37
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 72.97, with an EV/FCF ratio of -45.97.

EV / Earnings	-71.81
EV / Sales	1.03
EV / EBITDA	72.97
EV / EBIT	n/a
EV / FCF	-45.97

Financial Position

The company has a current ratio of 10.83

Current Ratio	10.83
Quick Ratio	9.66
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-1,051.69

Financial Efficiency

Return on equity (ROE) is -1.12% and return on invested capital (ROIC) is -2.98%.

Return on Equity (ROE)	-1.12%
Return on Assets (ROA)	-1.15%
Return on Invested Capital (ROIC)	-2.98%
Return on Capital Employed (ROCE)	-1.94%
Weighted Average Cost of Capital (WACC)	1.06%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.73
Inventory Turnover	10.40

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -4.44% in the last 52 weeks. The beta is -0.58, so Jeonjinbio's price volatility has been lower than the market average.

Beta (5Y)	-0.58
52-Week Price Change	-4.44%
50-Day Moving Average	2,273.44
200-Day Moving Average	2,922.21
Relative Strength Index (RSI)	49.82
Average Volume (20 Days)	312,540

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Jeonjinbio had revenue of KRW 13.69 billion and -195.81 million in losses. Loss per share was -22.00.

Revenue	13.69B
Gross Profit	3.74B
Operating Income	-342.85M
Pretax Income	-195.81M
Net Income	-195.81M
EBITDA	192.70M
EBIT	-342.85M
Loss Per Share	-22.00

Balance Sheet

The company has 6.41 billion in cash and n/a in debt, with a net cash position of 6.41 billion or 707.85 per share.

Cash & Cash Equivalents	6.41B
Total Debt	n/a
Net Cash	6.41B
Net Cash Per Share	707.85
Equity (Book Value)	17.41B
Book Value Per Share	2,065.92
Working Capital	8.60B

Cash Flow

In the last 12 months, operating cash flow was 483.19 million and capital expenditures -789.08 million, giving a free cash flow of -305.90 million.

Operating Cash Flow	483.19M
Capital Expenditures	-789.08M
Depreciation & Amortization	535.55M
Net Borrowing	-43.97M
Free Cash Flow	-305.90M
FCF Per Share	-33.77

Margins

Gross margin is 27.32%, with operating and profit margins of -2.50% and -1.43%.

Gross Margin	27.32%
Operating Margin	-2.50%
Pretax Margin	-1.43%
Profit Margin	-1.43%
EBITDA Margin	1.41%
EBIT Margin	-2.50%
FCF Margin	n/a

Dividends & Yields

Jeonjinbio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.42%
Shareholder Yield	-3.42%
Earnings Yield	-0.96%
FCF Yield	-1.49%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Jeonjinbio has an Altman Z-Score of 13.55 and a Piotroski F-Score of 3.

Altman Z-Score	13.55
Piotroski F-Score	3